CEO/Founder
Helaina
Helaina utilizes a proprietary technology platform to replicate human lactoferrin, a bioactive protein that enhances iron utilization, supports immune health, and maintains gut function. By making this functional ingredient accessible, Helaina addresses the need for advanced nutritional solutions that promote overall health and vitality.
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$83MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Many individuals lack access to the beneficial bioactive protein human lactoferrin, which is naturally present in the body and highly concentrated in human colostrum. This protein plays a crucial role in optimizing iron utilization, maintaining healthy gut function, and supporting immune health.
Solution
Helaina utilizes a proprietary technology platform to replicate human lactoferrin, making it accessible as a novel nutrient. Their effera™ Human Lactoferrin offers a science-backed solution to enhance iron utilization, support immune health, and maintain gut function. By replicating this functional ingredient, Helaina aims to establish a new standard for nutrition and address the need for advanced nutritional solutions that promote overall health and vitality.
Target Audience
Helaina's target audience includes individuals seeking advanced nutritional solutions to optimize iron utilization, maintain healthy gut function, and support immune health.
Features
- Proprietary technology platform for replicating human lactoferrin
- effera™ Human Lactoferrin ingredient
- Supports iron utilization
- Maintains healthy gut function
- Supports immune health
- Backed by clinical and preclinical studies (studies done on bovine and human lactoferrin)